PMID- 15036943
OWN - NLM
STAT- MEDLINE
DCOM- 20040722
LR  - 20151119
IS  - 0145-2126 (Print)
IS  - 0145-2126 (Linking)
VI  - 28 Suppl 1
DP  - 2004 May
TI  - Sweet's syndrome with CML cell infiltration of the skin in a patient with 
      chronic-phase CML while taking Imatinib Mesylate.
PG  - S61-3
AB  - Sweet's syndrome (acute febrile neutrophilic dermatosis) is characterized by an 
      acute onset of erythematous plaques, fever, and leukocytosis. This syndrome has 
      been reported to be associated with leukemia including chronic myelogenous 
      leukemia (CML). Sweet's syndrome seen in patients with leukemia is usually 
      associated with active and/or refractory disease. Imatinib Mesylate (STI-571, 
      Gleevec) is widely used for therapy of CML. In this case report, CML cell 
      infiltration of the skin was documented by fluorescence in situ hybridization 
      (FISH) analysis in a patient with chronic-phase CML on Imatinib Mesylate 
      (STI-571, Gleevec), who was at the time in molecular remission.
FAU - Liu, Delong
AU  - Liu D
AD  - New York Medical College and Zalmen A. Arlin Cancer Institute, Room 250, Munger 
      Pavilion, Valhalla, NY 10595, USA. delong_liu@nymc.edu
FAU - Seiter, Karen
AU  - Seiter K
FAU - Mathews, Thomas
AU  - Mathews T
FAU - Madahar, Cecily J
AU  - Madahar CJ
FAU - Ahmed, Tauseef
AU  - Ahmed T
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - England
TA  - Leuk Res
JT  - Leukemia research
JID - 7706787
RN  - 0 (Benzamides)
RN  - 0 (Piperazines)
RN  - 0 (Pyrimidines)
RN  - 8A1O1M485B (Imatinib Mesylate)
SB  - IM
CIN - Leuk Res. 2005 Feb;29(2):233-4. PMID: 15607374
MH  - Benzamides
MH  - Female
MH  - Humans
MH  - Imatinib Mesylate
MH  - In Situ Hybridization, Fluorescence
MH  - Leukemia, Myeloid, Chronic-Phase/complications/*pathology
MH  - Leukemic Infiltration/*diagnosis
MH  - Middle Aged
MH  - Piperazines/*therapeutic use
MH  - Pyrimidines/*therapeutic use
MH  - Remission Induction
MH  - Skin/pathology
MH  - Sweet Syndrome/*etiology/pathology
EDAT- 2004/03/24 05:00
MHDA- 2004/07/23 05:00
CRDT- 2004/03/24 05:00
PHST- 2003/04/22 00:00 [received]
PHST- 2003/07/03 00:00 [accepted]
PHST- 2004/03/24 05:00 [pubmed]
PHST- 2004/07/23 05:00 [medline]
PHST- 2004/03/24 05:00 [entrez]
AID - S0145212603002571 [pii]
AID - 10.1016/S0145-2126(03)00257-1 [doi]
PST - ppublish
SO  - Leuk Res. 2004 May;28 Suppl 1:S61-3. doi: 10.1016/S0145-2126(03)00257-1.